Exploring therapeutic decisions in elderly patients with non-small cell lung cancer: Results and conclusions from North central cancer treatment group study N0222

Cancer Investigation

Volumn 29, Issue 4, 2011, Pages 266-271

  Mc Kean, Heidi ^a   Stella, Philip J ^b   Hillman, Shauna L ^a   Rowland Jr , Kendrith M ^c   Cannon, Michael W ^d   Behrens, Robert J ^e   Gross, Gerald G ^f   Sborov, Mark D ^g   Friedman, Eliot L ^h   Jatoi, Aminah ^a  

^a MAYO CLINIC ROCHESTER   (United States)

^b Michigan Cancer Research Consortium   (United States)

^c Carle Cancer Center CCOP   (United States)

^d WICHITA COMMUNITY CLINICAL ONCOLOGY PROGRAM   (United States)

^e Iowa Oncology Research Association CCOP   (United States)

^f MeritCare Hospital   (United States)

^g Metro Minnesota Community Clinical Oncology Program   (United States)

^h LEHIGH VALLEY HOSPITAL   (United States)

Author keywords

Akt; Breast cancer; Mutation; PI3K; PIK3CA

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CARBOPLATIN; CREATININE; GEFITINIB; HEMOGLOBIN; PACLITAXEL;

AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANEMIA; ANOREXIA; AREA UNDER THE CURVE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CREATININE BLOOD LEVEL; DESQUAMATION; DIARRHEA; DRUG DOSE REDUCTION; DRUG TOLERABILITY; DYSPNEA; FATIGUE; FEMALE; FEVER; GERIATRIC PATIENT; HUMAN; INFECTION; INTERSTITIAL PNEUMONIA; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MALE; MOTOR NEUROPATHY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTHROMBIN TIME; QUESTIONNAIRE; RASH; SAMPLE SIZE; SENSORY NEUROPATHY; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT PLANNING; TREATMENT RESPONSE; TREATMENT WITHDRAWAL;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PACLITAXEL; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; QUINAZOLINES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 79953794948     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2010.535061     Document Type: Article

References (6)

1. Owonikoko TK, Ragin CC, Belani CP, Oton AB, Gooding WE, Taioli E, Ramalingan SS. Lung cancer in elderly patients: an analysis of the Surveillance, Epidemiology, and End Results Database. J Clin Oncol 2007 25:5570-5577.
2. Repetto L, Biganzoli L, Koehne CH, Luebbe AS, Soubeyran P, Tjan- Heijnen VC, Aapro MS, Yang CH, Chu DT, Saijo N, Sunpaweravong P, Han B,Margogno B, Ihinose Y, Nishikawi Y, Ohe Y, Yang JJ, Chewaskulyong B, Jiang H, Duffield EL, Watkins CL, Armour AA, Fukuoka M. EORTC cancer in the elderly task force guidelines for the use of colony-stimulating factors in elderly patients with cancer. Eur J Cancer 2003 39:2264-2272. (Pubitemid 37214850)
3. The Elderly Lung Cancer Vinorelbine Italian Study Group. Effect of vinorelbine on quality of life and survival of elderly patients with advanced non-small cell lung cancer. J Natl Cancer Inst 1999 91:66-72.
4. Wheatley-Price P, Ding K, Seymour L, Clark GM, Shepherd FA Erlotinib for advanced non-small cell lung cancer in the elderly: an analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR21. J Clin Oncol 2008 26:2350-2357.
5. Jatoi A, Stella PJ,Hillman S,MailliradJA, Vanone S, PerezEA, Cannon MW, Geyer S,Wiesenfeld M, Jett JR. Weekly carboplatin and paclitaxel in elderly non-small cell lung cancer patients: a phase II North Central Cancer Treatment Group study. Am J Clin Oncol 2003 26:441-447. (Pubitemid 37248259)
6. Mok TS, Wu YL, Thongprasert S, Yang CH, Chu DT, Saijo N, Sunpaweravong P, Han B, Margono B, Ihinose Y, Nishikawi Y, Ohe Y, Yang JJ, Chewaskulyong B, Jiang H, Duffield EL, Watkins CL, Armour AA, Fukuoka M. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009 361:947-957.